Medexus Pharmaceuticals Inc. MEDXF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.35M | 5.34M | 6.52M | 14.98M | 9.38M |
| Total Receivables | 14.30M | 13.09M | 14.86M | 11.83M | 12.08M |
| Inventory | 34.51M | 29.87M | 36.87M | 31.30M | 34.23M |
| Prepaid Expenses | 9.38M | 10.58M | 5.09M | 11.86M | 6.74M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 447.00K | -- | -- |
| Total Current Assets | 66.54M | 58.89M | 63.78M | 69.97M | 62.43M |
|
|
|||||
| Total Current Assets | 66.54M | 58.89M | 63.78M | 69.97M | 62.43M |
| Net Property, Plant & Equipment | 330.00K | 372.00K | 422.00K | 457.00K | 507.00K |
| Long-term Investments | 10.06M | 10.05M | 10.14M | 10.22M | 10.15M |
| Goodwill | 10.06M | 10.05M | 10.14M | 10.22M | 10.15M |
| Total Other Intangibles | 59.54M | 61.87M | 62.34M | 64.78M | 67.06M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.44M | 10.92M | 10.60M | 9.56M | 9.30M |
| Total Assets | 147.90M | 142.09M | 147.28M | 154.98M | 149.44M |
|
|
|||||
| Total Accounts Payable | 44.87M | 38.21M | 8.22M | 43.38M | 37.69M |
| Total Accrued Expenses | -- | -- | 38.33M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.91M | 2.39M | 2.21M | 7.20M | 20.95M |
| Total Finance Division Other Current Liabilities | 4.79M | 4.55M | 4.82M | 11.82M | 16.31M |
| Total Other Current Liabilities | 4.79M | 4.55M | 4.82M | 11.82M | 16.31M |
| Total Current Liabilities | 52.57M | 45.14M | 53.58M | 62.40M | 74.94M |
|
|
|||||
| Total Current Liabilities | 52.57M | 45.14M | 53.58M | 62.40M | 74.94M |
| Long-Term Debt | 23.16M | 23.65M | 19.79M | 18.08M | -101.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 151.00K | 207.00K | 262.00K | 76.00K | 219.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.47M | 25.02M | 24.66M | 22.22M | 21.96M |
| Total Liabilities | 99.35M | 94.03M | 98.29M | 102.77M | 97.02M |
|
|
|||||
| Common Stock & APIC | 105.54M | 105.89M | 107.28M | 107.77M | 108.15M |
| Retained Earnings | -63.03M | -63.85M | -64.39M | -61.71M | -61.79M |
| Treasury Stock & Other | 6.04M | 6.03M | 6.10M | 6.15M | 6.06M |
| Total Common Equity | 48.55M | 48.07M | 48.99M | 52.21M | 52.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.55M | 48.07M | 48.99M | 52.21M | 52.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.55M | 48.07M | 48.99M | 52.21M | 52.42M |
|
|
|||||